I know it was FDA staff evaluation documentation release on Friday but that pretty much gave a good idea that the advisory panel is going to recommend approval. Again, its the FDA advisory panel that recommended approval today. FDA does not have to necessarily go by the advisory panel comments but they usually do. So the approval by FDA, in April, will not be a surprise. Market makes huge moves on surprises (good or bad) so hoping for a muted response tomorrow and should trade as general market trend.